Drug-related problems in the community setting: Pharmacists' findings and recommendations for people with mental illnesses

Clinical Drug Investigation

Volumn 26, Issue 7, 2006, Pages 415-425

  Bell, J Simon ^a   Whitehead, Paula ^b   Aslani, Parisa ^a   McLachlan, Andrew J ^a   Chen, Timothy F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; CARDIOVASCULAR AGENT; CHOLINESTERASE INHIBITOR; DERMATOLOGICAL AGENT; HYPNOTIC AGENT; IMMUNOMODULATING AGENT; NEUROLEPTIC AGENT; SEDATIVE AGENT; SEX HORMONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMMUNITY; CONTROLLED STUDY; DRUG INFORMATION; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; INTERVIEW; MALE; MEDICAL PRACTICE; MENTAL DISEASE; PATIENT REFERRAL; PHARMACIST; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; COMMUNITY PHARMACY SERVICES; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PHYSICIANS, FAMILY;

EID: 33745236057     PISSN: 11732563     EISSN: 11732563     Source Type: Journal    
DOI: 10.2165/00044011-200626070-00003     Document Type: Article

References (57)

1. Field TS, Gilman BH, Subramanian S, et al. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care 2005; 43: 1171-6
2. Miller GC, Britt H, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust 2006; 184: 321-4
3. Second National Report on patient safety: improving medication safety. Canberra: Commonwealth Department of Health and Ageing, 2002
4. Motl S, Timpe E, Eichner S. Proposal to improve MedWatch: decentralized, regional surveillance of adverse drug reactions. Am J Health Syst Pharm 2004; 61: 1840-2
5. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107-16
6. Hartikainen SA, Rahkonen T, Kautianen H, et al. Use of psychotropics among home dwelling non-demented and demented elderly. Int J Geriatr Psychiatry 2003; 18: 1135-41
7. Fialova D, Topinkova E, Finne-Soveri H, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293: 1348-58
8. Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004; 164: 305-12
9. Fick DM, Cooper JW, Wade WE, et al. Updating the beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003; 163: 2716-24
10. Hartikainen SA, Mantyselka P, Louhivuori-Laako K, et al. Concomitant use of analgesics and psychotropics in home-dwelling elderly people: Kuopio 75+ study. Br J Clin Pharmacol 2005; 60: 306-10
11. Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd, 2005
12. Lambert T, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. Med J Aust 2003; 178: S67-70
13. Merle L, Laroche M-L, Dantoine T, et al. Predicting and preventing adverse drug reactions in the very old. Drugs Aging 2005; 22: 375-92
14. Linjakumpu TA, Hartikainen SA, Klaukka TJ, et al. Psychotropics among the home dwelling elderly: increasing trends. Int J Geriatr Psychiatry 2002; 17: 874-83
15. Mort JR, Aparasu RR. Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Arch Intern Med 2000; 160: 2825-31
16. Bhasale AL, Miller GC, Reid SE, et al. Analysing potential harm in Australian general practice: an incident monitoring study. Med J Aust 1998; 169: 73-6
17. Roughead EE, Lexchin J. Adverse drug events: counting is not enough, action is needed. Med J Aust 2006; 184: 315-6
18. Garfield S, Francis S-A, Smith FJ. Building concordant relationships with patients starting antidepressant medication. Patient Educ Couns 2004; 55: 241-6
19. Olofinjana B, Taylor D. Antipsychotic drugs: information and choice: a patient survey. Psychiatr Bull 2005; 29: 369-71
20. Vainio KK, Airaksinen M, Hyykky TT, et al. Effect of therapeutic class on counselling in community pharmacies. Ann Pharmacother 2002; 36: 781-6
21. Happell B, Manias E, Roper C. Wanting to be heard: mental health consumers' experiences of information about medication. Int J Ment Health Nurs 2004; 13: 242-8
22. Hamann J, Cohen R, Leucht S, et al. Do patients with schizophrenia wish to be involved in decision about their medical treatment? Am J Psychiatry 2005; 162: 2382-4
23. National Strategy for the Quality Use of Medicines: Commonwealth of Australia, 2002 [online]. Available from URL: http://www.health.gov.au/internet/ wcms/publishing.nsf/Content/nmp-pdf-natstrateng-cnt.htm [Accessed 2006 Jun 7]
24. Bell S, McLachlan AJ, Aslani P, et al. Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Aust New Zealand Health Policy 2005; 2: 29
25. Finley PR, Crimson ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy 2003; 23: 1634-44
26. Schmidt IK, Fastbom J. Quality of drug use in Swedish nursing homes: a follow up study. Clin Drug Invest 2000; 20: 433-46
27. Harvey KJ. The pharmaceutical benefits scheme 2003-2004. Aust New Zealand Health Policy 2005; 2: 2
28. Gilbert AL, Roughead EE, Beilby J, et al. Collaborative medication management services: improving patient care. Med J Aust 2002; 177: 189-92
29. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification System. Norwegian Institute of Public Health. Available from URL: http: //www.whocc.no/filearchive/word/internet.doc [Accessed 2006 Mar 10]
30. Jones M, Whitehead P. Classifying the process of medication management review [abstract]. Pharm Educ 2004; 4: 213
31. Roughead EE, Barratt JD, Gilbert AL. Medication related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf 2004; 13: 83-7
32. Lambert TJR, Chapman L, Australian Consensus Working Group. Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement. Med J Aust 2004; 181 (10): 544-8
33. Taylor D, Young C, Esop R, et al. Testing for diabetes in hospitalised patients prescribed antipsychotic drugs. Br J Psychiatry 2004; 185: 152-6
34. Greening J. Physical health of patients in rehabilitation and recovery: a survey of case note records. Psychiatr Bull 2005; 29: 210-2
35. Shulman RW, Ozdemir V. Psychotropic medications and cytochrome P4502D6: pharmacokinetic considerations in the elderly. Can J Psychiatry 1997; 42: S4-9
36. Linjakumpu TA, Hartikainen SA, Klaukka TJ, et al. Sedative drug use in the home dwelling elderly. Ann Pharmacother 2004; 38: 2017-22
37. Valenstein M, Khanujua K, Austin K, et al. Benzodiazepine use among depressed patients treated in mental health settings. Am J Psychiatry 2004; 161: 654-61
38. Wang PS, Bohn RL, Glynn RJ, et al. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, duration and risk of hip fracture. Am J Psychiatry 2001; 158: 892-8
39. Schmidt I, Claesson CB, Westerholm B, et al. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 1998; 46: 77-82
40. Hartlaub PP, Barrett PH, Marine WM, et al. Evaluation of an intervention to change benzodiazepine-prescribing behavior in a prepaid group practice setting. Am J Prev Med 1993; 9: 346-52
41. Evans S, Taylor J, Walker R. Evaluation of a primary care-based temazepam withdrawal programme [abstract]. Int J Pharm Pract 2002; 10: R79
42. Badger E. The pharmacist's role in the medicinal management of depression. Nurs Stand 2002; 16: 33-40
43. Landers M, Blenkinsopp A, Pollock K, et al. Community pharmacists and depression: the pharmacist as intermediary between patient and physician. Int J Pharm Pract 2002; 10: 253-65
44. Lin EHB, Katon W, von Korff M, et al. Relationship of depression, diabetes self-care, medication adherence and preventative care. Diabetes Care 2004; 27: 2154-60
45. Kalsekar ID, Madhavan SS, Amonkar MM, et al. Depression in patients with type II diabetes: impact on adherence to oral hypoglycemic agents. Ann Pharmacother 2006; 40 (4): 605-11
46. Bane C, Hughes CM, McElnay JC. The impact of depressive symptoms and psychosocial factors of medication adherence in cardiovascular disease. Patient Educ Couns 2006; 60: 187-93
47. Targeting depression in primary care. Sydney: National Prescribing Service, 2004 [online]. Available from URL: http://www.nps.org.au/site.php? content=/html/news.php&news=/resources/NPS_News/news35 [Accessed 2006 Jun 7]
48. Brook O, van Hout H, Nieuwenhuyse H, et al. Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial. Eur Neuropsychopharmacol 2003; 13: 1-9
49. Finley PR, Rens HR, Pont JT, et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy 2003; 23: 1175-85
50. Adler DA, Bungay KM, Wilson IB, et al. The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry 2004; 26: 199-209
51. Jorm AF, Christensen H, Griffiths KM, et al. Effectiveness of complementary and self-help treatments for depression. Med J Aust 2002; 176: S84-95
52. Jorm AF, Christensen H, Griffiths KM, et al. Effectiveness of complementary and self-help treatments for anxiety disorders. Med J Aust 2004; 181: S29-46
53. Carney SL. Medication accuracy and general practitioner referral letters. Intern Med J 2006; 36: 132-4
54. Holland R, Elizabeth L, Harvey I, et al. Does home based medication review keep older people out of hospital?. The HOMER randomised controlled trial. BMJ 2005; 330: 292-8
55. Allard J, Hebert R, Maryse R, et al. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ 2001; 164: 1291-6
56. Blakeman T, Harris M, Comino E, et al. Evaluating general practitioners' views about the implementation of the Enhanced Primary Care Medicare items. Med J Aust 2001; 175: 95-8
57. Davis R, Thurecht R. Care planning and case conferencing: building effective multidisciplinary teams. Aust Fam Physician 2001; 30: 78-81